Nomination Committee

The nomination committee is a shareholders’ committee that has responsibility for nominating directors to be appointed at the annual shareholders’ meeting.

According to the Swedish Corporate Governance Code, the nomination committee is required to have at least three members, the majority of which must not be members of the Board of Directors. Neither the managing director or other members of the executive management may be members of the nomination committee. In addition, no member of the Board of Directors may assume the position as chairman of the nomination committee . 

The nomination committee is to propose candidates for the post of chair and other members of the Board of Directors, as well as fees and other remuneration to each member of the Board of Directors. The nomination committee is also to present proposals on the election and remuneration of the statutory auditor. Such recommendations shall be presented at the annual shareholders’ meeting.

The shareholders’ meeting is to appoint members of the nomination committee or to specify how they are to be appointed and to provide written instructions to the nomination committee. 

At the Annual General Meeting on May 9, 2019 it was resolved that Swedish Orphan Biovitrum AB (publ) shall have a nomination committee consisting of four members: the Chairman of the Board of Directors and one representative for each of the three largest shareholders in the Company based on shareholder statistics from Euroclear Sweden AB as per the last banking day in August.

The Annual General Meeting 2019 adopted Instruction & Charter for the Nomination Committee that includes the tasks of the Nomination Committee and the procedure for appointing its members. The instruction applies until the General Meeting of shareholders resolve otherwise. The document is available for download on this page.

The nomination committee of the Annual General Meeting on May 8, 2025 consists of:

• Daniel Nodhäll, appointed by Investor AB
• Thomas Ehlin, appointed by Fjärde AP-fonden (AP4)
• Anders Hansson, appointed by AMF – Tjänstepension och Fonder
• David Meek, as Chair of the Board of Swedish Orphan Biovitrum AB (publ)

For information to shareholders on how to submit proposals to the Nomination Committee, please follow this link.